International Cooperative Ataxia Rating Scale (ICARS): appropriate for studies of Friedreich's ataxia?
Identifieur interne : 001406 ( Ncbi/Merge ); précédent : 001405; suivant : 001407International Cooperative Ataxia Rating Scale (ICARS): appropriate for studies of Friedreich's ataxia?
Auteurs : Stefan J. Cano [Royaume-Uni] ; Jeremy C. Hobart ; Paul E. Hart ; L V Prasad Korlipara ; Anthony H V. Schapira ; J Mark CooperSource :
- Movement disorders : official journal of the Movement Disorder Society [ 0885-3185 ] ; 2005.
English descriptors
- KwdEn :
- Adolescent, Adult, Child, Disability Evaluation, Female, Friedreich Ataxia (diagnosis), Friedreich Ataxia (physiopathology), Humans, International Cooperation, Male, Middle Aged, Models, Statistical, Neurologic Examination (methods), Neurologic Examination (standards), Psychometrics (legislation & jurisprudence), Psychometrics (methods), Psychometrics (standards), Reproducibility of Results, Sensitivity and Specificity, Severity of Illness Index, Sickness Impact Profile.
- MESH :
- diagnosis : Friedreich Ataxia.
- legislation & jurisprudence : Psychometrics.
- methods : Neurologic Examination, Psychometrics.
- physiopathology : Friedreich Ataxia.
- standards : Neurologic Examination, Psychometrics.
- Adolescent, Adult, Child, Disability Evaluation, Female, Humans, International Cooperation, Male, Middle Aged, Models, Statistical, Reproducibility of Results, Sensitivity and Specificity, Severity of Illness Index, Sickness Impact Profile.
Abstract
Clinicians require scientifically rigorous, clinically meaningful rating scales to evaluate the health impact of disease and treatment that cannot be measured using conventional laboratory instruments. This study evaluated the psychometric properties of the International Cooperative Ataxia Rating Scale (ICARS), a commonly used clinician-rated measure, in Friedreich's ataxia (FRDA). People with confirmed FRDA were assessed by using the ICARS. Two assumptions of its measurement model were tested: the legitimacy of reporting ICARS scores in FRDA, and the acceptability, reliability, and validity of total and subscale scores. Seventy-seven people with FRDA were assessed. The ICARS total score effectively satisfied all psychometric criteria tested. The posture and gait disturbances subscale also performed well. The other three subscales did not pass standard criteria for tests of scaling assumptions, reliability, and validity. This small study recommends only the use of the ICARS total score as a measure of FRDA. However, the extent to which this score quantifies the true extent of FRDA remains uncertain as our validity testing was limited, partly by the lack of appropriate validating measures. Further validity testing, and examination of responsiveness, is required before the ICARS can be recommended as an outcome measure for treatment trials of FDRA.
DOI: 10.1002/mds.20651
PubMed: 16114019
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 002F06
- to stream PubMed, to step Curation: 002F06
- to stream PubMed, to step Checkpoint: 003093
Links to Exploration step
pubmed:16114019Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">International Cooperative Ataxia Rating Scale (ICARS): appropriate for studies of Friedreich's ataxia?</title>
<author><name sortKey="Cano, Stefan J" sort="Cano, Stefan J" uniqKey="Cano S" first="Stefan J" last="Cano">Stefan J. Cano</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Clinical Neurosciences, Royal Free & University College Medical School, London, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Department of Clinical Neurosciences, Royal Free & University College Medical School, London</wicri:regionArea>
<placeName><settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Hobart, Jeremy C" sort="Hobart, Jeremy C" uniqKey="Hobart J" first="Jeremy C" last="Hobart">Jeremy C. Hobart</name>
</author>
<author><name sortKey="Hart, Paul E" sort="Hart, Paul E" uniqKey="Hart P" first="Paul E" last="Hart">Paul E. Hart</name>
</author>
<author><name sortKey="Korlipara, L V Prasad" sort="Korlipara, L V Prasad" uniqKey="Korlipara L" first="L V Prasad" last="Korlipara">L V Prasad Korlipara</name>
</author>
<author><name sortKey="Schapira, Anthony H V" sort="Schapira, Anthony H V" uniqKey="Schapira A" first="Anthony H V" last="Schapira">Anthony H V. Schapira</name>
</author>
<author><name sortKey="Cooper, J Mark" sort="Cooper, J Mark" uniqKey="Cooper J" first="J Mark" last="Cooper">J Mark Cooper</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2005">2005</date>
<idno type="doi">10.1002/mds.20651</idno>
<idno type="RBID">pubmed:16114019</idno>
<idno type="pmid">16114019</idno>
<idno type="wicri:Area/PubMed/Corpus">002F06</idno>
<idno type="wicri:Area/PubMed/Curation">002F06</idno>
<idno type="wicri:Area/PubMed/Checkpoint">003093</idno>
<idno type="wicri:Area/Ncbi/Merge">001406</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">International Cooperative Ataxia Rating Scale (ICARS): appropriate for studies of Friedreich's ataxia?</title>
<author><name sortKey="Cano, Stefan J" sort="Cano, Stefan J" uniqKey="Cano S" first="Stefan J" last="Cano">Stefan J. Cano</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Clinical Neurosciences, Royal Free & University College Medical School, London, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Department of Clinical Neurosciences, Royal Free & University College Medical School, London</wicri:regionArea>
<placeName><settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Hobart, Jeremy C" sort="Hobart, Jeremy C" uniqKey="Hobart J" first="Jeremy C" last="Hobart">Jeremy C. Hobart</name>
</author>
<author><name sortKey="Hart, Paul E" sort="Hart, Paul E" uniqKey="Hart P" first="Paul E" last="Hart">Paul E. Hart</name>
</author>
<author><name sortKey="Korlipara, L V Prasad" sort="Korlipara, L V Prasad" uniqKey="Korlipara L" first="L V Prasad" last="Korlipara">L V Prasad Korlipara</name>
</author>
<author><name sortKey="Schapira, Anthony H V" sort="Schapira, Anthony H V" uniqKey="Schapira A" first="Anthony H V" last="Schapira">Anthony H V. Schapira</name>
</author>
<author><name sortKey="Cooper, J Mark" sort="Cooper, J Mark" uniqKey="Cooper J" first="J Mark" last="Cooper">J Mark Cooper</name>
</author>
</analytic>
<series><title level="j">Movement disorders : official journal of the Movement Disorder Society</title>
<idno type="ISSN">0885-3185</idno>
<imprint><date when="2005" type="published">2005</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adolescent</term>
<term>Adult</term>
<term>Child</term>
<term>Disability Evaluation</term>
<term>Female</term>
<term>Friedreich Ataxia (diagnosis)</term>
<term>Friedreich Ataxia (physiopathology)</term>
<term>Humans</term>
<term>International Cooperation</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Models, Statistical</term>
<term>Neurologic Examination (methods)</term>
<term>Neurologic Examination (standards)</term>
<term>Psychometrics (legislation & jurisprudence)</term>
<term>Psychometrics (methods)</term>
<term>Psychometrics (standards)</term>
<term>Reproducibility of Results</term>
<term>Sensitivity and Specificity</term>
<term>Severity of Illness Index</term>
<term>Sickness Impact Profile</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Friedreich Ataxia</term>
</keywords>
<keywords scheme="MESH" qualifier="legislation & jurisprudence" xml:lang="en"><term>Psychometrics</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Neurologic Examination</term>
<term>Psychometrics</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Friedreich Ataxia</term>
</keywords>
<keywords scheme="MESH" qualifier="standards" xml:lang="en"><term>Neurologic Examination</term>
<term>Psychometrics</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adolescent</term>
<term>Adult</term>
<term>Child</term>
<term>Disability Evaluation</term>
<term>Female</term>
<term>Humans</term>
<term>International Cooperation</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Models, Statistical</term>
<term>Reproducibility of Results</term>
<term>Sensitivity and Specificity</term>
<term>Severity of Illness Index</term>
<term>Sickness Impact Profile</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Clinicians require scientifically rigorous, clinically meaningful rating scales to evaluate the health impact of disease and treatment that cannot be measured using conventional laboratory instruments. This study evaluated the psychometric properties of the International Cooperative Ataxia Rating Scale (ICARS), a commonly used clinician-rated measure, in Friedreich's ataxia (FRDA). People with confirmed FRDA were assessed by using the ICARS. Two assumptions of its measurement model were tested: the legitimacy of reporting ICARS scores in FRDA, and the acceptability, reliability, and validity of total and subscale scores. Seventy-seven people with FRDA were assessed. The ICARS total score effectively satisfied all psychometric criteria tested. The posture and gait disturbances subscale also performed well. The other three subscales did not pass standard criteria for tests of scaling assumptions, reliability, and validity. This small study recommends only the use of the ICARS total score as a measure of FRDA. However, the extent to which this score quantifies the true extent of FRDA remains uncertain as our validity testing was limited, partly by the lack of appropriate validating measures. Further validity testing, and examination of responsiveness, is required before the ICARS can be recommended as an outcome measure for treatment trials of FDRA.</div>
</front>
</TEI>
<pubmed><MedlineCitation Owner="NLM" Status="MEDLINE"><PMID Version="1">16114019</PMID>
<DateCreated><Year>2005</Year>
<Month>11</Month>
<Day>07</Day>
</DateCreated>
<DateCompleted><Year>2006</Year>
<Month>03</Month>
<Day>21</Day>
</DateCompleted>
<DateRevised><Year>2007</Year>
<Month>08</Month>
<Day>13</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Print">0885-3185</ISSN>
<JournalIssue CitedMedium="Print"><Volume>20</Volume>
<Issue>12</Issue>
<PubDate><Year>2005</Year>
<Month>Dec</Month>
</PubDate>
</JournalIssue>
<Title>Movement disorders : official journal of the Movement Disorder Society</Title>
<ISOAbbreviation>Mov. Disord.</ISOAbbreviation>
</Journal>
<ArticleTitle>International Cooperative Ataxia Rating Scale (ICARS): appropriate for studies of Friedreich's ataxia?</ArticleTitle>
<Pagination><MedlinePgn>1585-91</MedlinePgn>
</Pagination>
<Abstract><AbstractText>Clinicians require scientifically rigorous, clinically meaningful rating scales to evaluate the health impact of disease and treatment that cannot be measured using conventional laboratory instruments. This study evaluated the psychometric properties of the International Cooperative Ataxia Rating Scale (ICARS), a commonly used clinician-rated measure, in Friedreich's ataxia (FRDA). People with confirmed FRDA were assessed by using the ICARS. Two assumptions of its measurement model were tested: the legitimacy of reporting ICARS scores in FRDA, and the acceptability, reliability, and validity of total and subscale scores. Seventy-seven people with FRDA were assessed. The ICARS total score effectively satisfied all psychometric criteria tested. The posture and gait disturbances subscale also performed well. The other three subscales did not pass standard criteria for tests of scaling assumptions, reliability, and validity. This small study recommends only the use of the ICARS total score as a measure of FRDA. However, the extent to which this score quantifies the true extent of FRDA remains uncertain as our validity testing was limited, partly by the lack of appropriate validating measures. Further validity testing, and examination of responsiveness, is required before the ICARS can be recommended as an outcome measure for treatment trials of FDRA.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cano</LastName>
<ForeName>Stefan J</ForeName>
<Initials>SJ</Initials>
<AffiliationInfo><Affiliation>Department of Clinical Neurosciences, Royal Free & University College Medical School, London, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Hobart</LastName>
<ForeName>Jeremy C</ForeName>
<Initials>JC</Initials>
</Author>
<Author ValidYN="Y"><LastName>Hart</LastName>
<ForeName>Paul E</ForeName>
<Initials>PE</Initials>
</Author>
<Author ValidYN="Y"><LastName>Korlipara</LastName>
<ForeName>L V Prasad</ForeName>
<Initials>LV</Initials>
</Author>
<Author ValidYN="Y"><LastName>Schapira</LastName>
<ForeName>Anthony H V</ForeName>
<Initials>AH</Initials>
</Author>
<Author ValidYN="Y"><LastName>Cooper</LastName>
<ForeName>J Mark</ForeName>
<Initials>JM</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y"><Grant><Agency>Wellcome Trust</Agency>
<Country>United Kingdom</Country>
</Grant>
</GrantList>
<PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
<PublicationType UI="D023361">Validation Studies</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>Mov Disord</MedlineTA>
<NlmUniqueID>8610688</NlmUniqueID>
<ISSNLinking>0885-3185</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName MajorTopicYN="N" UI="D000293">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D002648">Child</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D004185">Disability Evaluation</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D005621">Friedreich Ataxia</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="Y" UI="D007391">International Cooperation</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D015233">Models, Statistical</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D009460">Neurologic Examination</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000592">standards</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D011594">Psychometrics</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000331">legislation & jurisprudence</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000592">standards</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D015203">Reproducibility of Results</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D012680">Sensitivity and Specificity</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="Y" UI="D012720">Severity of Illness Index</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D018434">Sickness Impact Profile</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2005</Year>
<Month>8</Month>
<Day>23</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2006</Year>
<Month>3</Month>
<Day>22</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2005</Year>
<Month>8</Month>
<Day>23</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="doi">10.1002/mds.20651</ArticleId>
<ArticleId IdType="pubmed">16114019</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>Royaume-Uni</li>
</country>
<region><li>Angleterre</li>
<li>Grand Londres</li>
</region>
<settlement><li>Londres</li>
</settlement>
</list>
<tree><noCountry><name sortKey="Cooper, J Mark" sort="Cooper, J Mark" uniqKey="Cooper J" first="J Mark" last="Cooper">J Mark Cooper</name>
<name sortKey="Hart, Paul E" sort="Hart, Paul E" uniqKey="Hart P" first="Paul E" last="Hart">Paul E. Hart</name>
<name sortKey="Hobart, Jeremy C" sort="Hobart, Jeremy C" uniqKey="Hobart J" first="Jeremy C" last="Hobart">Jeremy C. Hobart</name>
<name sortKey="Korlipara, L V Prasad" sort="Korlipara, L V Prasad" uniqKey="Korlipara L" first="L V Prasad" last="Korlipara">L V Prasad Korlipara</name>
<name sortKey="Schapira, Anthony H V" sort="Schapira, Anthony H V" uniqKey="Schapira A" first="Anthony H V" last="Schapira">Anthony H V. Schapira</name>
</noCountry>
<country name="Royaume-Uni"><region name="Angleterre"><name sortKey="Cano, Stefan J" sort="Cano, Stefan J" uniqKey="Cano S" first="Stefan J" last="Cano">Stefan J. Cano</name>
</region>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Ncbi/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001406 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 001406 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Santé |area= MovDisordV3 |flux= Ncbi |étape= Merge |type= RBID |clé= pubmed:16114019 |texte= International Cooperative Ataxia Rating Scale (ICARS): appropriate for studies of Friedreich's ataxia? }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i -Sk "pubmed:16114019" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd \ | NlmPubMed2Wicri -a MovDisordV3
![]() | This area was generated with Dilib version V0.6.23. | ![]() |